Your browser doesn't support javascript.
loading
Tsyn-Seq: a T-cell Synapse-Based Antigen Identification Platform.
Jin, Yimei; Miyama, Takahiko; Brown, Alexandria; Hayase, Tomo; Song, Xingzhi; Singh, Anand K; Huang, Licai; Flores, Ivonne I; McDaniel, Lauren K; Glover, Israel; Halsey, Taylor M; Prasad, Rishika; Chapa, Valerie; Ahmed, Saira; Zhang, Jianhua; Rai, Kunal; Peterson, Christine B; Lizee, Gregory; Karmouch, Jennifer; Hayase, Eiko; Molldrem, Jeffrey J; Chang, Chia-Chi; Tsai, Wen-Bin; Jenq, Robert R.
Affiliation
  • Jin Y; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Miyama T; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Brown A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hayase T; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Song X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Singh AK; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Huang L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Flores II; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • McDaniel LK; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Glover I; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Halsey TM; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Prasad R; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chapa V; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ahmed S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Rai K; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Peterson CB; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lizee G; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Karmouch J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hayase E; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Molldrem JJ; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chang CC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tsai WB; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jenq RR; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer Immunol Res ; 12(5): 530-543, 2024 May 02.
Article in En | MEDLINE | ID: mdl-38363296
ABSTRACT
Tools for genome-wide rapid identification of peptide-major histocompatibility complex targets of T-cell receptors (TCR) are not yet universally available. We present a new antigen screening method, the T-synapse (Tsyn) reporter system, which includes antigen-presenting cells (APC) with a Fas-inducible NF-κB reporter and T cells with a nuclear factor of activated T cells (NFAT) reporter. To functionally screen for target antigens from a cDNA library, productively interacting T cell-APC aggregates were detected by dual-reporter activity and enriched by flow sorting followed by antigen identification quantified by deep sequencing (Tsyn-seq). When applied to a previously characterized TCR specific for the E7 antigen derived from human papillomavirus type 16 (HPV16), Tsyn-seq successfully enriched the correct cognate antigen from a cDNA library derived from an HPV16-positive cervical cancer cell line. Tsyn-seq provides a method for rapidly identifying antigens recognized by TCRs of interest from a tumor cDNA library. See related Spotlight by Makani and Joglekar, p. 515.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Antigen, T-Cell / T-Lymphocytes / Immunological Synapses Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Cancer Immunol Res Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Antigen, T-Cell / T-Lymphocytes / Immunological Synapses Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Cancer Immunol Res Year: 2024 Document type: Article